VELZE 500
VELZE 500
(Sodium Valproate & Valproic Acid Control Released Tablets)
n
Composition:
nEach controlled release tablet contains:
n
nSodium Valproate                            I.P.                 333 mg
n
nValproic Acid                                    I.P.                  145 mg
n
nExcipients                                                                  q.s.
n
Packaging:
n10 × 10 Tablets
Product Description
VELZE 500 is a controlled-release combination of Sodium Valproate (333 mg) and Valproic Acid (145 mg), providing sustained anticonvulsant and mood-stabilizing effects. It acts by increasing GABA levels through inhibition of its degradation, while also blocking voltage-gated sodium channels and T-type calcium channels, leading to stabilization of neuronal activity and suppression of abnormal electrical discharges.
n
nThe controlled-release formulation ensures prolonged action and improved patient compliance with reduced dosing frequency. VELZE 500 is indicated for the management of epilepsy and bipolar disorder.
n
Indications:
n
-
n
- Epilepsy (generalized and partial seizures, including absence, tonic-clonic, and myoclonic seizures)
- Bipolar disorder (management of acute mania and mood stabilization)
n
n
n
Therapeutic Segment Positioning:
nAnticonvulsants (Neurology)
